The Open University
QN-302-Mediated G-Quadruplex Stabilisation in Liposarcoma: A Dual Hit Strategy to Restore p53 and Reprogram Innate Immune Response
Abstract
dc:description.abstractDedifferentiated liposarcoma (DDLPS) is a rare and aggressive soft tissue sarcoma (STS) characterised by poor prognosis and limited therapeutic options. A defining molecular hallmark of DDLPS is the amplification of the 12q13–q15 chromosomal region, leading to the pathological overexpression of the E3 ubiquitin ligase MDM2 and consequent functional inactivation of the p53 tumour suppressor protein. The MDM2 promoter is enriched in guanine-rich sequences capable of forming non-canonical DNA secondary structures known as G-quadruplexes (G4). G4s are broadly enriched at telomeres and oncogene promoters. They have emerged as attractive therapeutic targets for small-molecule G4 ligands (G4-L), as stabilisation of G4s can repress transcription, impair DNA replication, and induce DNA damage. Increasing evidence further suggests that G4-L-induced genotoxic stress may activate the innate immune cGAS-STING pathway, thereby linking genome instability to tumour immunogenicity. In this PhD project, the therapeutic potential of the experimental G4-L QN-302, which has recently entered Phase I clinical trial in solid tumours, was investigated in DDLPS models. The study aimed to dissect the dual mechanism of action of QN-302, both as a targeted transcriptional repressor of MDM2 and as an inducer of tumour-intrinsic innate immune signalling. In summary, our results showed: 1) The direct molecular effects of QN-302 were first characterised in two in-house patient-derived DDLPS cell lines, both harbouring MDM2 amplification and an enriched G4 landscape compared to normal pre-adipocytes. The compound stabilised G4 structures within the MDM2 promoter, repressing MDM2 transcription and disrupting the MDM2-p53 feedback loop, thereby restoring p53-dependent apoptosis. In parallel, QN-302 downregulated ATRX and topoisomerase IIIα, key regulators of replication stress tolerance, leading to replication fork stress and accumulation of DNA double-strand breaks, as evidenced by increased γ-H2AX levels. 2) Given the established link between DNA damage induction, micronuclei formation, and innate immune response activation, the immunological consequences of QN-302–induced genotoxic stress were subsequently examined. Treatment of DDLPS cells with QN-302 promoted micronuclei formation, triggering the activation of the innate immune cGAS-STING pathway. This resulted in an interferon (IFN) response, leading to the expression of a defined interferon-stimulated gene (ISG) core program. These effects were paralleled by QN-302-induced upregulation of the immune checkpoint ligand PD-L1. 3) To assess the broader relevance of these findings, we extended our analyses to large-scale transcriptomic datasets from The Cancer Genome Atlas (TCGA) and the Cancer Cell Line Encyclopedia (CCLE). Across pan-cancer models and soft-tissue sarcomas, we identified a universal, tumour-intrinsic immunogenic visibility and adaptive resistance axis (termed the visibility-resistance axis) wherein the ISG core is tightly coupled with both antigen processing and presentation (APP) and a four-gene immune checkpoint ligand signature (ICL-4: CD274, PDCD1LG2, LGALS9, and CEACAM1). Clinical evaluation in retroperitoneal sarcoma and DDLPS cohorts revealed that this ISG-high state is associated with improved overall survival, suggesting that enhanced immunogenic visibility can outweigh baseline adaptive resistance. These findings reinforce the biological coupling between tumour-intrinsic immunogenic visibility and adaptive resistance, establishing the ISG core as a transcriptomic surrogate biomarker for this immunogenic state. Ultimately, this study provides a rationale for using DNA-damage-inducing agents, such as QN-302, and innate immune modulators to effectively prime the tumour-intrinsic environment, creating a specific druggable vulnerability that can be exploited through synergising with dual PD-1/TIM-3 blockade in DDLPS.
Degree
thesis:*- Name dc:type.qualificationname
- phd
- Level dc:type.qualificationlevel
- doctoral
- Grantor dc:publisher.institution
- The Open University
- Year dc:date.issued
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Naghshineh, Eisa
Rights
- Language dc:language
- en